July 14, 2010 - The Senate Finance Committee released a report on its investigation into whether drug manufacturer GlaxoSmtihKline withheld information regarding risks of their diabetes drug Avandia. On Tuesday the committee released their findings stating, "The Finance Committee inquiry uncovered documents suggesting that GlaxoSmithKline, the manufacturer of Avandia, failed to publish studies that found serious health risks associated with Avandia in a timely manner and actively promoted the drug despite the known safety concerns."
MAPLight.org created a heat map of contributions from the drug manufacturer to all members of Congress from 2000-2010.
Below are the contributions totals to Senate Finance Committee members from 2004-2010. According to data provided by Opensecrets.org, Sens. John Kerry (D-Mass.), Debbie Stabenow (D-Mich.), Maria Cantwell (D-Wash.), Bill Nelson (R-Fla.) and Olympia Snowe (R-Maine) did not receive contributions from GlaxoSmithKline during this time period.
Senate Finance Members contributions:
| Recipient | Total |
| Robert Menendez | $17,000 |
| Michael Crapo | $14,000 |
| Jon Kyl | $11,500 |
| Blanche Lincoln | $10,000 |
| John Cornyn | $10,000 |
| Michael Enzi | $10,000 |
| Max Baucus | $9,500 |
| Jim Bunning | $9,000 |
| Kent Conrad | $9,000 |
| John Ensign | $8,000 |
| Jeff Bingaman | $7,000 |
| Orrin Hatch | $7,000 |
| Thomas Carper | $6,000 |
| Charles Grassley | $3,500 |
| Pat Roberts | $3,500 |
| Charles Schumer | $1,000 |
| John Rockefeller | $1,000 |
| Ron Wyden | $1,000 |
